corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 8417

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Dearing A.
Enabling Europe to innovate.
Science 2007 Jan 19; 315:(5810):344-7
http://www.sciencemag.org/cgi/content/full/315/5810/344


Abstract:

As activities that relate to innovation become increasingly global and open and so draw the private and public sectors into complex networks of partnerships, these activities also tend to concentrate where the ecosystem is most supportive. European public policy, which in recent years has emphasized the importance of research and development (R&D) in achieving competitive knowledge-based societies, is shifting toward approaches that address the broader qualities required of favorable ecosystems for innovation in a global economy, thereby incorporating the roles of market demand, public procurement, and regulation, as well as science, education, and industrial R&D, as part of determining effective innovation policies.

Keywords:
Publication Types: Research Support, Non-U.S. Gov't Review MeSH Terms: Biotechnology Commerce Diffusion of Innovation* Drug Industry Europe European Union* Industry* Internationality Private Sector Public Policy* Public Sector Research*

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963